Explore

Trendline Trendline
Bio-Techne and Refeyn Launch Integrated Workflow for Antibody Characterization

Bio-Techne and Refeyn Launch Integrated Workflow for Antibody Characterization

Bio-Techne and Refeyn Launch Integrated Workflow for Antibody Characterization
Trendline Trendline
IDBS i3 2026 Forum Highlights Data-Driven Innovations in BioPharma

IDBS i3 2026 Forum Highlights Data-Driven Innovations in BioPharma

IDBS i3 2026 Forum Highlights Data-Driven Innovations in BioPharma
Trendline Trendline
Aurinia Pharmaceuticals Reports LUPKYNIS Reduces Renal-Related Risks in Lupus Nephritis Patients

Aurinia Pharmaceuticals Reports LUPKYNIS Reduces Renal-Related Risks in Lupus Nephritis Patients

Aurinia Pharmaceuticals Reports LUPKYNIS Reduces Renal-Related Risks in Lupus Nephritis Patients
Trendline Trendline
Lotte Biologics to Showcase Songdo Plant 1 at BIO USA Convention

Lotte Biologics to Showcase Songdo Plant 1 at BIO USA Convention

Lotte Biologics to Showcase Songdo Plant 1 at BIO USA Convention
Trendline Trendline
Cytek Biosciences to Showcase New Spectral Flow Cytometry Innovations at CYTO 2026

Cytek Biosciences to Showcase New Spectral Flow Cytometry Innovations at CYTO 2026

Cytek Biosciences to Showcase New Spectral Flow Cytometry Innovations at CYTO 2026
Trendline Trendline
Massachusetts Life Sciences Employment Declines After 14 Years of Growth, Future Projections Optimistic

Massachusetts Life Sciences Employment Declines After 14 Years of Growth, Future Projections Optimistic

Massachusetts Life Sciences Employment Declines After 14 Years of Growth, Future Projections Optimistic
Trendline Trendline
Alnylam and Inceptive Partner to Accelerate RNAi Therapeutics Discovery with AI

Alnylam and Inceptive Partner to Accelerate RNAi Therapeutics Discovery with AI

Alnylam and Inceptive Partner to Accelerate RNAi Therapeutics Discovery with AI
Trendline Trendline
Regeneron Expands Partnership with CytomX, Potentially Adding $2 Billion and Eight Targets

Regeneron Expands Partnership with CytomX, Potentially Adding $2 Billion and Eight Targets

Regeneron Expands Partnership with CytomX, Potentially Adding $2 Billion and Eight Targets
Trendline Trendline
Nirrin Technologies Introduces TALOS for Enhanced Biopharmaceutical Protein Quantitation

Nirrin Technologies Introduces TALOS for Enhanced Biopharmaceutical Protein Quantitation

Nirrin Technologies Introduces TALOS for Enhanced Biopharmaceutical Protein Quantitation
Trendline Trendline
Decoy Therapeutics Nominates Patricia Gauthier for Board of Directors to Enhance Antiviral Strategy

Decoy Therapeutics Nominates Patricia Gauthier for Board of Directors to Enhance Antiviral Strategy

Decoy Therapeutics Nominates Patricia Gauthier for Board of Directors to Enhance Antiviral Strategy
Trendline Trendline
Bruker Unveils High-Resolution Mass Spectrometer at ASMS 2026, Enhancing Molecular Analysis

Bruker Unveils High-Resolution Mass Spectrometer at ASMS 2026, Enhancing Molecular Analysis

Bruker Unveils High-Resolution Mass Spectrometer at ASMS 2026, Enhancing Molecular Analysis
Trendline Trendline
SGS Acquires CMIC, INC. to Enhance Bioanalytical Testing in North America

SGS Acquires CMIC, INC. to Enhance Bioanalytical Testing in North America

SGS Acquires CMIC, INC. to Enhance Bioanalytical Testing in North America